Results 111 to 120 of about 4,502 (185)

Enlightening the "Spirit Molecule": Photomodulation of the 5-HT_2A Receptor by a Light-Controllable N,N-Dimethyltryptamine Derivative. [PDF]

Angew Chem Int Ed Engl, 2022
Gerwe H, He F, Pottie E, Stove C, Decker M.   +4 more
europepmc   +1 more source

N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences. [PDF]

Neuropsychopharmacology
Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML.   +6 more
europepmc   +1 more source

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. [PDF]

Psychopharmacology (Berl), 2022
Barker SA.
europepmc   +1 more source

Disintegration of Default Mode: Functional MRI Insights Into N,N-Dimethyltryptamine (DMT), Consciousness, and Subcortical Connectivity. [PDF]

Cureus
Avakian A.
europepmc   +1 more source

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). [PDF]

J Neurochem, 2022
Reckweg JT, Uthaug MV, Szabo A, Davis AK, Lancelotta R, Mason NL, Ramaekers JG.   +6 more
europepmc   +1 more source

Detection and Quantification of Psychoactive N,N‑Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry

ACS Omega, 2020
Megan I. Chambers, Meghan G. Appley, Cameron M. Longo, Rabi A. Musah   +3 more
doaj   +1 more source

Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-<i>N,N</i>-dimethyltryptamine in Mice. [PDF]

ACS Pharmacol Transl Sci, 2023
Glatfelter GC, Naeem M, Pham DNK, Golen JA, Chadeayne AR, Manke DR, Baumann MH.   +6 more
europepmc   +1 more source

Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis. [PDF]

Clin Pharmacokinet
van der Heijden KV, Otto ME, Schoones JW, van Esdonk MJ, Borghans LGJM, van Hasselt JGC, van Gerven JMA, Jacobs G.   +7 more
europepmc   +1 more source

Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders. [PDF]

ACS Med Chem Lett, 2022
Kargbo RB.
europepmc   +1 more source

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers. [PDF]

Front Pharmacol, 2021
Reckweg J, Mason NL, van Leeuwen C, Toennes SW, Terwey TH, Ramaekers JG.   +5 more
europepmc   +1 more source